Tocilizumab and Desensitization in Kidney Transplant Candidates: Personal Experience and Literature Review

Desensitization (DES) allows kidney transplantation for highly HLA-sensitized subjects. Due to the central role of IL-6 in the immunological response, tocilizumab may improve DES efficacy. Thus, we conducted a PubMed systematic review using the MeSH terms tocilizumab, interleukin-6, kidney transplan...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinhard, Jules, Noble, Johan, Jouve, Thomas, Malvezzi, Paolo, Rostaing, Lionel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509506/
https://www.ncbi.nlm.nih.gov/pubmed/34640377
http://dx.doi.org/10.3390/jcm10194359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509506/
https://www.ncbi.nlm.nih.gov/pubmed/34640377
http://dx.doi.org/10.3390/jcm10194359

Ejemplares similares